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Slllmmal-y 
MRL-Ipr mice develop aggressive autoimmune kidney disease associated with increased or de 
novo renal expression of major histocompatibility  complex (MHC) dass II molecules and a massive 
systemic expansion of CD4-CD-  double negative (DN) T  cells. Whereas non-MHC linked 
genes can have a profound effect on the development of nephritis, lymphadenopathy, and anti- 
DNA antibody production in MRL-~r mice, the role of MHC molecules has not been unequivocally 
established. To study the role ofMHC dass II in this murine model of systemic lupus erythematosis, 
class II-deficient MRL-Ipr mice (MRL-Ipr  -/-)  were created. MRL-Ipr  -/-  mice developed 
lymphadenopathy  but not autoimmune renal disease or autoantibodies. This study demonstrates 
that class II expression is critical for the development of autoaggressive  CD4 + T cells involved 
in autoimmune nephritis and dearly dissociates DN T cell expansion from autoimmune disease 
initiation. 
~  ~[ RL-Mp-lpr/lpr  (MRL-Ipr) 1 mice  spontaneously de- 
J.u  velop an autoimmune disorder characterized by an im- 
mune complex glomerulonephritis, arthritis, vasculitis, and 
autoantibodies to nudeic acids (1). Although these mice do 
not precisdy represent human autoimmune disease, shared 
immunopathologic and serologic features make this an ac- 
cepted model of human SLE or lupus (2). MRL-Ipr mice 
homozygous for the Ipr gene develop massive lymphadenop- 
athy due to the influx of abnormal double negative (DN) 
T cells which express CD3 but not CD4 or CD8 accessory 
molecules (3, 4). The Ipr gene represents a loss of function 
mutation in theirs gene located on murine chromosome 19, 
resulting in defective apoptosis and DN T cell expansion (2, 
5-7). Although data exists to support defects in both posi- 
tive and negative thymic selection, detailed TCR V3 reper- 
toire analysis of CD4 +, CD8 +, and DN T cell populations 
would support the suggestion that normal thymic selection 
processes exist despite the absence of./fis (8-10). DN cells may 
originate from early CD4-CD8-  T cell precursors or more 
likely from "neglected" CD4 +  , CD8 + , dull TCR + T cells, 
with loss of accessory molecules and proliferation after es- 
cape to LN or liver mediated by a peripheral fas defect (3, 
10,  11). The lpr mutation does not directly cause autoim- 
mune disease, as the congenic strain MILL +/+  develops late 
1 Abbreviations used in this paper: DN, double negative; MILL-Ipr,  MRL- 
Mp-lpr/lpr;  wt, wild type. 
onset autoimmune syndrome, and homozygous expression 
of the lpr gene backcrossed  to nonautoimmune susceptible 
strains leads to lymphadenopathy and autoantibodies, but not 
to aggressive and rapid renal disease (12). It is therefore ap- 
parent that whereas the MRL background is required for au- 
toimmune disease to develop, Ipr accelerates rather than causes 
disease, and other as yet unidentified factors influence the ex- 
pression of disease. 
DN T cells do not appear to be essential for initiation of 
disease. Mice homozygous for the Ipr mutation and trans- 
genic for a class I-restricted ol/~/TCR specific for male (H-Y) 
antigen  do  not  generate  CD4-CDS-  T  cells  yet  have 
similar levels of autoantibodies, although the effect on lymph- 
adenopathy may vary with mouse strains (3, 4, 13). Whereas 
in vitro studies of fleshly isolated DN cells from MRL-Ipr 
mice demonstrate transcription of IFNq: and TNF-c~ mRNA 
(14), DN T cells may not produce these as biologically active 
cytokines in vivo (11, 15). However,  these cells may not be 
totally functionally inert as DN T cell clones have been shown 
to induce MHC class II and intercellular adhesion molecule 
1 (ICAM-1) expression on renal tubular cell epithelia, sug- 
gesting a role in promoting renal disease (16). Despite the 
massive expansion ofDN T cells, increased absolute numbers 
of CD4 + T  cells in adult MRL-Ipr mice could accelerate 
nephritis by inducing renal MHC expression and augmenting 
antibody production with low-level expression of cytokines 
such as IFN-3'  (15). Consistent with this concept, lupus 
1137  J. Exp. Med. ￿9  The Rockefeller  University  Press ￿9 0022-1007/94/04/1137/07 $2.00 
Volume 179  April  1994  1137-1143 nephritis is associated with increased  or de novo renal ex- 
pression of both adhesion and MHC class II molecules (17, 
18). Although clinical improvement occurs with treatments 
leading to reduced class II expression  or limiting CD4 + T 
cell interaction, the benefit from such treatments is limited, 
and a critical role for class II molecules in the development 
of renal immune injury has not been unequivocally estab- 
lished (19-22). 
The advent of gene targeting in embryonic stem cells has 
allowed the inactivation of specific genes in the immune system 
to examine their function. Mice devoid of cell surface expres- 
sion of MHC class II molecules have been created by in- 
troducing a loss of function mutation of the A~  b gene in 
ES-D3 (H-2  b) calls, which have a naturally occurring muta- 
tion in their E~ gene (23). Thus, the subsequent phenotype 
of these mice is a deficiency in the expression  of both I-A 
and I-E molecules. To definitively test the importance of these 
molecules  in  autoimmune  nephritis,  we  produced  class 
II-defident MRL-lpr mice and followed these mice for the 
development of kidney disease and autoantibody production. 
Despite the development of  lymphadenopathy  and DN T ceU 
expansion, class II-defident MRL-Ipr mice did not produce 
IgM or IgG autoantibodies, and were protected from the ag- 
gressive autoimmune renal injury associated with this model. 
Materials and Methods 
Mice.  Class  II--deficient  MILL-lpr  mice were created by repeat- 
edly backcrossing mice heterozygous for the disrupted A~  b allele 
(23) to MR.blpr/Ipr  mice (H-2  k) (Jackson Laboratory,  Bar Harbor, 
ME). Mice were screened  for the disrupted allele  by Southern blot- 
ting of BamHI-digested tail genomic DNA, using chemilumines- 
cent detection (Boehringer Mannheim Canada, Laval, Quebec, 
Canada) of a digoxigenin-labded genomic probe for A~  b as previ- 
ously described (23). An F6 heterozygous intercross which was 
more than 98% homozygous for non-MHC linked loci, produced 
mice homozygous for the disrupted class II As gene (MRL-Ipr 
-/-) and homozygous wild-type (MRDIpr  wt/wt) control mice 
as well as heterozygous (MILL lpr -/wt) mice. Initial littermate 
cohorts of 13-15 mice  per group were maintained in laminar flow 
hoods, given sterile food and water, and treated according to Cana- 
dian Council on Animal Care guidelines. 
Materials  and Histology.  Reagents were obtained from GIBCO 
BRL (Gaithersburg, MD), and chemicals  were obtained  from Sigma 
Chemical Co. (St. Louis, MO). The mAbs 10-2,16 (I-Ak), B21-2 
(I-Ab), GK1.5 (CD4), and 2.43 (CD8) (American Type Culture 
Collection, Rockville,  MD) were prepared by protein G purification 
and biotinylated using a standard protocol. Supematant from the 
145-2Cll hybridoma (CD3) was kindly provided by Dr. B. Singh 
(University of Western Ontario, London, Canada). Histology of 
kidney tissue was performed using hematoxylin and eosin staining 
of formalin (10%)-fixed kidney sections. For immunoperoxidase, 
4-/~m cryostat  sections  of  OCT (Miles, Etobicoke,  Ontario, Canada)- 
embedded tissue were acetone  fixed,  blocked  with 4% horse serum, 
and incubated with saturating concentrations of biotinylated pri- 
mary antibody, followed  by Vectastain  ABC reagent (Vector  Labora- 
tories, Burlingame, CA). Peroxidase  activity was detected by a 4-6- 
min incubation with 3,3' diaminobenzidine  (0.5 mg/ml) containing 
0.02% H202. Counterstaining was with methyl green and alcian 
blue. Irrelevant mAb of the same isotype were used for negative 
controls. 
Clinical and Histological  Scoring.  Weights and urinary protein 
levds were assessed  weekly. Urinary protein was monitored by al- 
bumin reagent  strips (Albustix;  Miles) and recorded as 0-4 + 
(1 + =  0.3 g/liter, 2 + .=  1 g/liter, 3 + =  3 g/liter and 4 §  =  >4 
g/liter).  Valtles >1 + are pathological in mice. Arbitrary clinical 
scoring of  nodes was assigned  by an observer  blinded to group iden- 
tities, using a scale of  0-4 (0 = none; 1 = a single node anywhere; 
2 = bilateral axillary; femoral, or cervical nodes; 3 = generalized 
femoral, axillary, and cervical nodes; and 4 = massive  generalized 
adenopathy). Serum was obtained by retro-orbital plexus sampling 
at 20 wk and serum creatinine  levels  were determined by a modified 
Jaffe method using an automated CX5 clinical analyzer (Beckman 
Instruments, Fullerton,  CA). Hemamxylin  and eosin-stained  kidney 
sections were scored for histopathological glomerular damage by 
a blinded observer, using a scale of 0-4 as previously  described (20) 
(0  =  no involvement; 1 =  mild changes in <25% of glomemli; 
2 = mild to moderate changes in 25-50%; 3 = moderate to severe 
changes in 50-75%, with crescent formation, and vasculitis; 4 = 
severe glomerulonephritis  with changes in >90%, and with sclerotic 
glomeruli). Additionally, the degree of mononuclear cell infiltra- 
tion was scored  in arbitrary units 0-4 (0 = none; 1 = few in some 
fields; 2 = moderate in most fields; 3 =  moderate in most fields; 
3 = moderate in all fields; 4 = severe  infiltrates  with loss of  normal 
surrounding histology). 
Flow Cytoraetry.  Single  cell suspensions were prepared from 
spleens and LN of MILL-Iprwt/wt and MILL-Ipr -/-  mice. 1.5 x 
106 cells were dual labeled with biotinylated mAb 10-2.16 (I-Ak), 
GK1.5 (CD4) or  2.43 (CD8),  and  nonbiotinylated  145-2Cll 
(anti-mouse CD3). Cells were washed with HBSS, 1% FCS, and 
0.1% NAN3, and then incubated with streptavidin-PE (Jackson 
ImmunoResearch, Avondale, PA)  and a fluorescein-conjugated 
F(ab')2 fragment  of goat  anti-hamster  antibody  (Jackson Im- 
munoResearch). Cells were washed, fixed in 2% paraformaldehyde, 
and analyzed  by flow cytometry (FACStar  Plus|  Becton Dickinson 
& Co., Mountain View, CA) using 20,000 events for each analysis. 
ELISA.  Flat bottom 96-well  microtiter plates (Falcon, Missis- 
sanga, Canada) were coated with single-stranded (ss)DNA (50 
/~g/rnl) overnight at 4~  in PBS, blocked  at room temperature  with 
1% gelatin, incubated  with sera from 20-wk-old  mice, hbeled with 
biotinylated anti-Ig (Jackson ImmunoResearch) at a 1:5,001) dilu- 
tion, followed  by phosphatase-conjugated  streptavidin (Jackson Im- 
munoResearch). Absorbance  of  color products was read at 405 nm 
after addition of substrate (p-nitrophenyl  phosphate disodium), fixa- 
tion with 3 N NaOH, and washing with 0.01 M PBS, 0.05% 
Tween, 0.2% gelatin, and 0.02% Na azide between steps. Each 
sample was run as a serial dilution and compared with standard 
curves of IgG or IgM (Sigma Chemical Co.) dilutions mn on the 
same plate. 
Statis~s.  Statistical  analyses,  where applicable, were performed 
using Statview IV software (Abacus Concepts, Berkeley, CA) on 
a Macintosh  LC computer (Apple Computer, Inc., Cupertino, CA). 
Differences between groups were compared by one way analysis 
of variance and unpaired t tests. All results are expressed as mean 
_+  SEM. 
Results and Discussion 
Lyrnphadenopat~ in Class II--deficient  Mice.  To prevent ex- 
posure to pathogens, all mice were isolated in laminar flow 
facilities and given sterile food and water. Under these con- 
ditions, mice were generaUy healthy and all had equivalent 
weight gains during the first 5-6 mo (Fig.  1). As expected, 
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>50% of the MRL-Ipr -/wt and MRL-Ipr  wt/wt had ad- 
vanced disease by 6 mo and most were dead or required eu- 
thanasia by 7-8 mo, because of severe renal failure. Several 
class II-expressing  homozygous MRL-Ipr wt/wt and het- 
erozygous MtLL-I  F  -/wt mice were euthanized before 6 mo 
as they demonstrated advanced signs of  disease. One homozy- 
gnus (1/13) MILL-Ipr -/-  mouse was killed at 4.5 mo be- 
cause of a large facial abscess, and several mice (3/12)  lost 
weight with fur raffling at the age of  6-7-mo, and were there- 
fore killed. Previous reports have noted an accelerated mor- 
tality rate in nonautoimmune strains of mice homozygous 
for the Ipr gene, possibly due to hemorrhagic necrosis of en- 
larged  LN  with  secondary  infection  (12). None  of the 
M1LL/Ipr -/-  mice that were euthanized had evidence of 
renal failure, systemic  pathogen infection, or other organ failure 
at the time of death. 
All mice developed lymphadenopathy by 6-7 mo which 
was similar in magnitude in homozygous wild type, hetero- 
zygous, and class II-ddident mice (Figs. 1 and 2). The pheno- 
Figure  1.  Analysis of weight gain and lymphadenopathy in MgL-Ipr 
-/-  mice. Littermate cohorts of  equal numbers of  male and female MR.blpr 
wt/wt (circles), MR.blpr  -/wt  (d/amonds), and MILL-Ipr -/-  (squares) 
(n  =  13 -  15 mice per group) were followed.  Mice were examined daily 
for clinical evidence of illness, and weekly for weight gain and the pres- 
ence of lymphadenopathy. (,'1) Weight gains were equal between groups. 
(/3 and C) Most mice in all groups developed lymphadenopathy between 
4 and 6 mo, and all had nodes by 7 mo (data not shown). Arbitrary  clinical 
scoring of nodes was assigned by an observer blinded to group identities, 
using a scale of 0-4 in Materials and Methods. Results are represented 
as mean  •  SEM. 
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Figure  2.  Developmentoflym- 
phadenopathy  in  MR.blpr -~- 
mice.  Class  II-deficient MRL-Ipr 
-/-  (/eft, aged 4.5 too) and class 
II expressing MILL-Ipr  wt/wt (right, 
aged 5 too) mice developed massive 
cervical and axillary  lymphadenop- 
atby typical of mice homozygous for 
the lpr mutation. MRL-lpr -I-  A 
3 
,r 
! 
a 
o 
MRL-Ipr wtlwt 
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Figure 3.  Flow cytometric analysis  of spleen lymphocyte subsets in class 
IF-deficient MRDIpr -/-  mice. Percentage of I-A  k positive cells (top, 
upper right quadrants) decreased from >70% in MRL-Ipr wt/wt mice to 
<1% in MRL,  Ipr -/-. CD3+CD4 * T cells (bottom, upper right quadrants) 
in MRL,  IFr wt/wt mice was <10% and not detectable in MRL, Ipr -~- 
mice. CD3+CD8 + T cells were not detected in 5-mo-old MRZ-lpr  wt/wt 
or MRL-lpr -/-  mice (data not shown).  Results are representative of 
three experiments, twice using one lpr wt/wt and Ipr -/-  mouse, and 
once with a single MILL-Ipr -/-  mouse. 
type of LN and spleen cells in the three groups was assessed 
by FACS  |  analysis and confirmed that by 20 wk in both spleen 
and LN, the predominant phenotype in all three groups of 
mice was CD3 +  CD4-  (Fig. 3), and CD3 +  CDS-  (data not 
shown). These results are consistent with previous reports 
defining the phenotype of DN T cells in wild-type MRL-Ipr 
mice, and the present data demonstrate that thymic MHC 
class II expression is not essential for the development of these 
abnormal DN T cells. Expression of CD4 during T cell matu- 
ration in the thymus does not require either I-A or I-E, but 
progression from CD4+CD8 + to single positive CD4 + T 
cells is dependent on dass II expression (23).  In MRL-Ipr 
wt/wt mice, a small number of CD3+CD4 + cells (<10%) 
persisted in spleen and LN cell populations at 5 mo (Fig. 
3),  but CD3+CD8 + cells were not detectable at this age 
(data  not shown). Previous reports have similarly demonstrated 
that by 20 wk of age, the massive expansion of DN cells 
can dilute the number of normal CD4 + and CD8 + T ceils, 
which are actually increased in absolute numbers, to nearly 
nondetectable levels in spleen or LN (15, 24). In contrast to 
MRL-/pr wt/wt mice, MtLL-Iyr -/-  mice did not have de- 
tectable levels of CD4 + T  ceils in either spleen (Fig.  3) or 
LN (data not shown). We have previously demonstrated the 
failure of CD4 + T cell development in "normal" dass II-de- 
ficient mice, and this holds true in the presence of the ab- 
normal thymic microenvironment produced by the absence 
of the J~s gene (5,  23). 
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Figure 4.  Analysis of kidney function in MRblpr -/-  mice. (.4 and 
B)  ~mt.tprwt/wt  (~i,~,),  t,,mt-l,~.  -/wt  W~''o'/'),  and  MPO_.@,  -~- 
(squares)  mice (n = 13-tS/group) were followed weekly for urinary pro- 
rein. None of the MRL,  Ipr -/-  mice developed significant proteinuria, 
whereas >50% of control MRL-Ipr wt/wt and MILL-Ipr -/wt mice de- 
veloped proteinuria by 24 wk. (C) MRL-Ipr -/-  mice had lower serum 
creatinine levels compared with control mice (p <0.05). Serum creatinine 
levels were determined in serum samples obtained from random MRDIpr 
-/-  mice (n  =  7) and MRL-Ipr wt/wt or MRL-Ipr -/wt mice (n  = 
7). Results are given as mean •  SEM; and (*) difference from control 
groups (p <0.05). 
Prevention of  Autoimmune Nephritis in MRL-Ipr -/-  Mice. 
Although autoimmune disease can progress independently 
oflymphadenopathy (4, 25), several reports have shown that 
neonatal thymectomy, cydosporine, or dexamethasone, reduces 
lymphadenopathy and ameliorates nephritis, suggesting that 
a link exists between peripheral DN T  cell expansion and 
the magnitude of autoimmune responses (4, 20, 24). Addi- 
1140  Class II-defident MRL-lpr Mice Figure 5.  Comparison of kidney histology in MRL-Ipr wt/wt and MILL-Ipr -/-  mice. (A) Sections from 24-28-wk-old  MRL-Ipr wt/wt kidneys 
showed marked periglomerular infiltrates, necrotizing  glomerulonephritis (open  arrows)  and (/3)  massive perivascular infiltrates with vasculitis (solid  arrow), 
which are typical in this strain by this age. Sections from MRL-Ipr -/wt mice had similar changes (data not shown). (C) In contrast, kidney structures 
were normal in MILL-Ipr -/-  mice with normal glomeruli (open arrows)  and blood vessds (solid  arrow), with no marked infiltrates. Kidney MHC 
class lI expression was assessed by immunoperoxidase using 10-2.16 (I-A  k) or B21-2 (I-A  s) mAb. Irrelevant mAb of the same isotype were used for 
negative controls, and control staining  shown for MILL-Ipr -/-  was not greater than shown for MRL-Ipr  wt/wt. (D) Expression of class II was increased 
in tubular cells, endothelium, mesangial cells, and infiltrating  cells in MRL-lpr wt/wt mice (E), but absent in MRL-Ipr -/-  (F). Staining with antibodies 
to I-A  b in MtLL-Ipr -/-  mice was not greater than background shown in (D). Figures are representative of five to seven mice in each group, with 
mean histopathological  scores of mice presented in Table 1.  •  x400. 
tionaUy  whereas mice homozygous  for lpr have both drculating 
autoantibodies and immune complexes,  B cell activity can 
be dissociated from immune injury (12, 24).  We therefore 
assessed the effect of class II deficiency on autoimmune dis- 
ease in an MRL-Ipr  by assessing the development  of nephritis. 
Initially,  mice were screened weekly for urinary protein ex- 
cretion, a sensitive marker of renal injury. By 6 too, when 
>50% of MRL-Ipr  wt/wt and MRL-Ipr -/wt mice had evi- 
dence of advanced renal disease, none of the MRL-Ipr -~- 
mice (0/12) had elevated urine protein levels (Fig. 4, A  and 
B). Consistent with these observations, at 5 mo of age, serum 
samples from MRL-Ipr  wt/wt and MRL-Ipr -/wt mice had 
elevated levels of creatinine in comparison with normal levels 
in homozygous MRL-Ipr -/-  mice (Fig.  4  C).  This is 
noteworthy as serum creatinine reflects glomerular filtration 
rate, and is increased only after a 50% reduction of normal 
kidney function has occurred. Histological scoring of kidney 
sections showed MRL-Ipr  wt/wt and MRL-Ipr -/wt mice 
had advanced renal injury consisting of a necrotizing glo- 
merulonephritis  with crescents, glomerulosderosis, and mas- 
sive periglomerular, interstitial, and perivascuhr infiltrates (Fig. 
5, A and B, Table 1). In contrast, renal histology was essen- 
tiaUy normal in MRL-Ipr -/-  mice, although some glomeruli 
had  mild mesangial expansion and  a  few periglomerular 
Table  1.  Histophathological  Scoring in Renal Injury in MRL-Ipr wt/wt,  MRL-Ipr  -/wt and MRL-Ipr  -/-  Mice. 
Infiltrate* 
Glomerular 
Type  histology*  n  Perivascular  Glomerular  Medulla 
MRL-Ipr  -/-  1.2  _+  0.2s  5  0.4  _+  0.2s  1.0  _+  0.3  s  0.6  _+  0.2S 
MRL-Ipr  -/wt  3.3  _+  0.3  7  3.3  _+  0.3  3.0  +  0.3  2.6  _+  0.5 
MRL-Ipr wt/wt  2.8  _+  0.4  5  3.8  _+  0.2  2.8  _+  0.2  1.8  _+  0.2 
24-28-wk-old MRL mice were euthanized,  and formalin-fixed kidney tissue was sectioned and stained with hematoxylin-eosin. 
* Slides were  scored for glomerular injury in a blinded manner, using a scale of 0-4 with 4 representing  severe changes. 
* Similarly, the degree of infiltration was scored in arbitrary units 0-4. A minimum of 10 fields were examined per section, counting between 20 
and 30 glomeruli. Results are reported  as mean _+  SEM. 
S Represents  difference from MRL-Ipr -/wt  and MRL-Ipr wt/wt control groups  (p <0.05). 
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to note that the presence of Ipr-related  lymphadenopathy in 
nonautoimmune prone strains of mice can result in subtle 
renal pathology abnormalities without overt nephritis (12). 
Renal expression of class II precedes overt nephritis in MRL- 
lpr mice and may be related to the local release of cytokines 
(17). Kidney sections were therefore assessed to confirm loss 
ofdass II expression in MRL-Ipr -/-. In both homozygous 
and heterozygous control mice, there was abundant expres- 
sion  of  class  II  on  tubular  epithelial  cells,  infiltrating 
mononuclear cells, and glomerular mesangial cells (Fig. 5 E). 
As expected, class II was absent in MRL-Ipr -/-  kidney 
sections (Fig. 5 F). Similarly, splenocytes and LN cells from 
5-mo-old MRL-Ipr -/-  mice did not express I-A  b (data not 
shown). 
Although MRL-Ipr -/-  mice had lymphadenopathy scores 
that were indistinguishable from both homozygous and het- 
erozygous control mice (Fig.  1 C), the pancity of infiltrates 
within class II-deficient kidneys might have been expected 
with a previous demonstration that preferential migration 
of CD4-CD8-  B220 + T cells to the kidney does not occur 
and most of the infiltrating cells within the kidneys of dis- 
eased MRL-Ipr mice are CD4 + T ceils (26).  Since CD8 + T 
cells do not require CD4 + T cells for normal development 
and function (27), our data suggest that autoimmune nephritis 
was  abrogated  in  these  class  II-deficient  MILL  mice by 
blocking autoaggressive CD4 + T cell generation within the 
thymus. Alternatively, since the development of autoreactive 
T  cells from MRL-Ipr mice in vitro has been shown to be 
dependent on the presence of class II-bearing APCs (28), 
it is possible that generation or proliferation of autoreactive 
CD4 + T  ceils within the kidney may not have occurred in 
the absence of renal MHC class II expression. The present 
data also suggest that since lymphadenopathy occurred de- 
spite blockage of normal thymic development of CD4 + T 
ceils,  single positive CD4 + T  ceils  are unlikely to be the 
precursor T cell phenotype giving rise to DN T cells in the 
periphery. This is consistent with recent data which suggest 
that DN T cells are positively selected on class I but not class 
II antigens (10). This hypothesis may be tested using avail- 
able  CD4 +  and CD8 +  deficient mice backcrossed to  the 
MRL-Ipr strain. 
Autoantibody  Production  in Class II-deficient  MRL-Ipr -l- 
Mice.  The MRL-Ipr strain of mouse also produces a large 
number of autoantibodies, including those directed against 
nucleic adds. The role of antibody in lupus nephritis in this 
model is not entirely clear as renal disease activity may not 
correlate with either antibody or immune complex levels (12, 
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Analysis of anti-ssDNA antibodies  was performed  by ELISA. 
Both MRL-Ipr  wt/wt and MILblpr -/wt mice (n  =  7) had high levels 
oflgM and IgG anti-ssDNA antibodies. In contrast, MR.L-Ipr -/- levels 
(n =  7) of IgM antibody levels were <1/zg/ml, and IgG levels were not 
detectable by this assay. Results are reported as mean + SEM, and repre- 
sent two experiments. 
24).  Although CD4 + T cell help is required for efficient B 
cell function and isotype switching, B cell hyperactivity can 
proceed even if T  cell proliferation is suppressed (24),  and 
therefore  we assessed  IgM and IgG anti-ssDNA antibody levels. 
Both homozygous and heterozygous MILL control mice had 
high levels of  both antibodies while MRL-Ipr -/-  mice had 
essentially nondetectable levels (Fig.  6).  Whereas it might 
be expected that with a functional loss of CD4 + T  helper 
T cells in class II-deficient mice, IgG levels of all specificities 
would be severely impaired in MRL-Ipr -/-  mice, the loss 
of IgM autoantibodies was interesting in that total IgM levels 
are preserved or even elevated in nonautoimmune prone strains 
of class II-deficient mice (23,  29). 
In summary, MRL-Ipr  mice deficient of MHC class II ex- 
pression do not develop autoimmune nephritis or autoanti- 
bodies. It is likely that disease was prevented in this novel 
strain by a lack of thymic class II expression which prevented 
autoaggressive T cell development. Whereas previous models 
have shown dissociation of disease and autoantibody produc- 
tion and various relationships between nephritis and lymph- 
adenopathy, this report clearly demonstrates that with loss 
of class II expression, the prevention of nephritis in an au- 
toimmune susceptible strain can occur in the presence of 
lymphadenopathy. Furthermore, the development of DN T 
cell-derived lymphadenopathy in a class II- and CD4 helper 
cell-deficient mouse suggests these mice may become an im- 
portant model in which to study the thymic and peripheral 
development of these abnormal T  cells. 
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